Abstract TH176: Performance of Contemporary Cardiovascular Risk Estimates Against 10-Year Cardiovascular Mortality Among U.S. Adults With Diabetes
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Juliet Zon und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Adults with diabetes have elevated cardiovascular mortality risk, but it remains unclear how contemporary risk tools perform against observed cardiovascular mortality in nationally representative U.S. adults with diabetes.
Methods
We pooled NHANES 1999-2008 data linked to public-use National Death Index mortality files through 2019 and compared PREVENT and SCORE2-Diabetes 10-year estimates with observed 10-year cardiovascular mortality. The sample included adults aged 40-69 years with diabetes, no self-reported coronary heart disease, angina, myocardial infarction, or stroke, and complete risk-score variables. Diabetes was defined by self-report or hemoglobin A1c >=6.5%. Observed cardiovascular mortality was death from diseases of heart or cerebrovascular disease within 120 months. PREVENT ASCVD and total CVD estimates were calculated using published equations in R. SCORE2-Diabetes used the published algorithm in R, with the Moderate-risk region as comparator. Discrimination was assessed using C-statistics, and agreement with observed mortality using observed-to-expected ratios.
Results
The final sample included 1,332 adults with diabetes; mean age was 56.8 years and 49.2% were female. During follow-up, 56 cardiovascular deaths occurred, corresponding to observed 10-year mortality of 4.2%. Mean predicted risk was 9.1% for PREVENT ASCVD, 15.0% for PREVENT total CVD, and 12.6% for SCORE2-Diabetes Moderate. PREVENT ASCVD and SCORE2-Diabetes Moderate showed similar discrimination, with C-statistics of 0.707, 95% CI 0.640-0.774, and 0.696, 95% CI 0.633-0.759. PREVENT total CVD showed the highest discrimination, C-statistic 0.730, 95% CI 0.664-0.796. All estimates exceeded observed mortality-only risk. Observed-to-expected ratios were 0.46 for PREVENT ASCVD, 0.33 for SCORE2-Diabetes Moderate, and 0.28 for PREVENT total CVD. Sensitivity analyses showed similar findings.
Conclusions
Among U.S. adults with diabetes in NHANES linked mortality data, PREVENT ASCVD and SCORE2-Diabetes showed similar discrimination against 10-year cardiovascular mortality. However, event-based risk estimates exceeded observed mortality, consistent with comparison against mortality-only outcomes. Contemporary risk estimates may rank cardiovascular mortality risk reasonably well but should not be interpreted as absolute cardiovascular mortality estimates without mortality-specific calibration.
Zitieren
APA
Zon, J., Dankwa, K., Yeboah, E., & Gbuchie, M. (2026). Abstract TH176: Performance of Contemporary Cardiovascular Risk Estimates Against 10-Year Cardiovascular Mortality Among U.S. Adults With Diabetes. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th176
Vancouver
Zon J, Dankwa K, Yeboah E, Gbuchie M. Abstract TH176: Performance of Contemporary Cardiovascular Risk Estimates Against 10-Year Cardiovascular Mortality Among U.S. Adults With Diabetes. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th176
BibTeX
@article{Zon2026,
author = {Zon, Juliet and Dankwa, Kwabena and Yeboah, Ekua and Gbuchie, Monica},
title = {Abstract TH176: Performance of Contemporary Cardiovascular Risk Estimates Against 10-Year Cardiovascular Mortality Among U.S. Adults With Diabetes},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th176}
}
EUVIMED